The 96-week clinical outcomes after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients

BACKGROUND: Chronic hepatitis B (CHB) patients have a high virological relapse rate after cessation of nucleos(t)ide analog (NA) treatment, but the clinical outcome remains unclear. This study aimed to investigate the 96-week clinical outcomes and the risk factors for relapse in CHB after cessation...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Wen-Xiong, Li, Yang-Mei, Li, Jian-Guo, Mei, Yong-Yu, Chen, You-Ming, Li, Xue-Jun, Lin, Chao-Shuang, Deng, Hong, Zhao, Zhi-Xin, Xie, Dong-Ying, Gao, Zhi-Liang, Peng, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460097/
https://www.ncbi.nlm.nih.gov/pubmed/34567563
http://dx.doi.org/10.1093/gastro/goab013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8460097/
https://www.ncbi.nlm.nih.gov/pubmed/34567563
http://dx.doi.org/10.1093/gastro/goab013

Ejemplares similares